TAHA KORAY ŞAHİN

Yayın Ağı

Makaleler 61

1. Oral selective estrogen receptor degraders (SERDs) in hormone receptor-positive HER2-negative metastatic breast cancer after progression with CDK4/6 inhibitors

ŞAHİN T. K., AKSOY S., GÜVEN D. C.

EXPERT REVIEW OF ANTICANCER THERAPY , sa.5, ss.471-484, 2025 (SCI-Expanded)

2. Efficacy of Second-Line Treatments After Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma and Related Prognostic Factors: A Multicenter Study by the Turkish Oncology Group (TOG)

Majidova N., YASLIKAYA Ş., Mildanoglu M. M., COŞKUN A., ERCAN UZUNDAL D., ŞAHİN T. K., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.36, sa.5, ss.293-301, 2025 (SCI-Expanded, Scopus, TRDizin)

3. Post-progression treatment options after CDK4/6 inhibitors in hormone receptor-positive, HER2-negative metastatic breast cancer

Sahin T. K., Rizzo A., GÜVEN D. C., AKSOY S.

CANCER TREATMENT REVIEWS , 2025 (SCI-Expanded, Scopus)

4. Fear of Cancer Recurrence and Associated Factors in Lymphoma Survivors and Their Family Caregivers: A Cross-Sectional Study

ŞAHİN T. K., Sahin E. A., Gungor H. N., GÜVEN D. C., BARIŞTA İ., AKIN S.

CANCER MEDICINE , sa.7, 2025 (SCI-Expanded, Scopus)

5. Modified cachexia index and survival in metastatic breast cancer patients treated with CDK 4-6 inhibitors

BAŞ O., Tokatli M., Savkliyildiz M., Yazarkan Y., Guduk N., Kilinc C., et al.

EXPERT REVIEW OF ANTICANCER THERAPY , sa.4, ss.405-409, 2025 (SCI-Expanded)

6. The association between blood sodium levels and survival in patients treated with immune checkpoint inhibitors

ŞAHİN T. K., GÜVEN D. C., Durukan M., KAVGACI G., KAYGUSUZ Y., ARIK Z., et al.

EXPERT REVIEW OF MOLECULAR DIAGNOSTICS , sa.4, ss.129-137, 2025 (SCI-Expanded)

7. The role of the microbiome in head and neck squamous cell cancers

ŞAHİN T. K., SÖNMEZER M. Ç.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY , sa.2, ss.623-637, 2025 (SCI-Expanded, Scopus)

8. The perspectives and knowledge of patients with cancer on mpox and mpox vaccination: a cross-sectional study

ŞAHİN T. K., KAYGUSUZ Y., Icli M. C., AKSOY S., GÜVEN D. C.

CURRENT MEDICAL RESEARCH AND OPINION , sa.1, ss.83-91, 2025 (SCI-Expanded, Scopus)

9. The association between HALP score and survival in patients treated with immune checkpoint inhibitors

ŞAHİN T. K., GÜVEN D. C., Durukan M., BAŞ O., KAYGUSUZ Y., ARIK Z., et al.

EXPERT REVIEW OF ANTICANCER THERAPY , sa.1, ss.81-89, 2025 (SCI-Expanded)

10. Post-operative serum CEA predicts prognosis in HR-positive/HER2-negative early breast cancer

KAVGACI G., ŞAHİN T. K., Muderrisoglu T., Ileri S., GÜVEN D. C., AKSOY S.

EXPERT REVIEW OF ANTICANCER THERAPY , sa.12, ss.1319-1326, 2024 (SCI-Expanded) Sürdürülebilir Kalkınma

11. Ribociclib-induced autoimmune-like hepatitis: a case report

KAVGACI G., ŞAHİN T. K., SÖKMENSÜER C., BALABAN H. Y., AKSOY S.

JOURNAL OF CHEMOTHERAPY , 2024 (SCI-Expanded, Scopus)

12. Prognostic Value of Neutrophil-to-Eosinophil Ratio (NER) in Cancer: A Systematic Review and Meta-Analysis

ŞAHİN T. K., Ayasun R., Rizzo A., Guven D. C.

CANCERS , cilt.16, sa.21, 2024 (SCI-Expanded, Scopus)

13. Prognostic impact of myosteatosis on survival with immune checkpoint inhibitors: A systematic review and meta-analysis

Sahin T. K., Guven D. C.

CLINICAL NUTRITION ESPEN , cilt.63, ss.829-836, 2024 (ESCI, Scopus)

14. Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine

ŞAHİN T. K., AKYILDIZ A., DOĞAN O. T., KAVGACI G., GÜVEN D. C., AKSOY S.

PHARMACEUTICALS , cilt.17, sa.7, 2024 (SCI-Expanded, Scopus)

15. Prognostic Significance of the Royal Marsden Hospital (RMH) Score in Patients with Cancer: A Systematic Review and Meta-Analysis

Sahin T. K., Rizzo A., AKSOY S., Guven D. C.

CANCERS , cilt.16, sa.10, 2024 (SCI-Expanded, Scopus)

16. The association between HER2-low status and survival in patients with metastatic breast cancer treated with Cyclin-dependent kinases 4 and 6 inhibitors: a systematic review and meta-analysis

Guven D. C., Sahin T. K.

Breast Cancer Research and Treatment , cilt.204, sa.3, ss.443-452, 2024 (SCI-Expanded, Scopus)

17. Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy

Sahin T. K., ÖZBAY Y., ALTUNBULAK A. Y., ALTUNBULAK H. İ., ONUR M. R., Ceylan F., et al.

International Journal of Clinical Oncology , 2024 (SCI-Expanded, Scopus)

18. Immunotherapy in the First-Line Treatment of Advanced Nasopharyngeal Carcinoma: A Systematic Review and Meta-Analysis

GÜVEN D. C., Stephen B., ŞAHİN T. K., ÇAKIR İ. Y., AKSOY S.

Laryngoscope , cilt.134, sa.1, ss.7-17, 2024 (SCI-Expanded, Scopus)

19. Diagnostic performance and longitudinal analysis of fungal biomarkers in COVID-19 associated pulmonary aspergillosis

ER B., ER A. G., GÜLMEZ KIVANÇ D., ŞAHİN T. K., METAN G., SARIBAŞ Z., et al.

Heliyon , cilt.9, sa.11, 2023 (SCI-Expanded, Scopus)

20. The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort study

GÜVEN D. C., Yekeduz E., Erul E., YAZGAN S. C., ŞAHİN T. K., KARATAŞ G., et al.

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , cilt.149, sa.7, ss.3599-3606, 2023 (SCI-Expanded, Scopus)

21. The incidence and risk factors for acute kidney injury in patients treated with immune checkpoint inhibitors

GÜVEN D. C., ÖZBEK D. A., ŞAHİN T. K., KAVGACI G., Aksun M. S., ERUL E., et al.

Anti-Cancer Drugs , cilt.34, sa.6, ss.783-790, 2023 (SCI-Expanded, Scopus)

22. Modulation of inflammation by phytochemicals to enhance efficacy and reduce toxicity of cancer chemotherapy

ŞAHİN T. K., Bilir B., Kucuk O.

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION , cilt.63, sa.15, ss.2494-2508, 2023 (SCI-Expanded, Scopus)

23. Retrospective Evaluation of the Efficacy of Gemcitabine-Based Therapies After FOLFIRINOX Failure in Advanced Pancreatic Cancer, Multi-Center Real-Life Data

Sütcüoğlu O., Doğan A., Yilmaz F., Şahin A. B., ŞAHİN T. K., Esen S. A., et al.

Pancreas , cilt.52, sa.4, 2023 (SCI-Expanded, Scopus)

24. Prognostic and predictive value of tumoral DNA damage repair protein expression in patients with resected pancreatic cancer

Ceylan F., Guven D. C., Taban H., Aktepe O., ŞAHİN T. K., Kilickap S., et al.

Clinics and Research in Hepatology and Gastroenterology , cilt.47, sa.3, 2023 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

25. Knowledge and Attitudes of Turkish Physicians towards Human Monkeypox Disease and Related Vaccination: A Cross-Sectional Study

ŞAHİN T. K., ERUL E., AKSUN M. S., SÖNMEZER M. Ç., ÜNAL S., AKOVA M.

Vaccines , cilt.11, sa.1, 2023 (SCI-Expanded, Scopus)

26. The association between albumin levels and survival in patients treated with immune checkpoint inhibitors: A systematic review and meta-analysis

GÜVEN D. C., ŞAHİN T. K., ERUL E., Rizzo A., Ricci A. D., AKSOY S., et al.

Frontiers in Molecular Biosciences , cilt.9, 2022 (SCI-Expanded, Scopus)

27. The Use of Phytochemicals to Improve the Efficacy of Immune Checkpoint Inhibitors: Opportunities and Challenges

GÜVEN D. C., ŞAHİN T. K., Rizzo A., Ricci A. D., AKSOY S., ŞAHİN K.

APPLIED SCIENCES-BASEL , cilt.12, sa.20, 2022 (SCI-Expanded, Scopus)

28. Independent predictors of in-hospital mortality and the need for intensive care in hospitalized non-critical COVID-19 patients: a prospective cohort study

ÇALIK BAŞARAN N., ÖZDEDE M., UYAROĞLU O. A., ŞAHİN T. K., ÖZCAN B., ORAL H., et al.

INTERNAL AND EMERGENCY MEDICINE , cilt.17, sa.5, ss.1413-1424, 2022 (SCI-Expanded, Scopus)

29. The Association between Early Changes in Neutrophil-Lymphocyte Ratio and Survival in Patients Treated with Immunotherapy

GÜVEN D. C., ŞAHİN T. K., Erul E., ÇAKIR İ. Y., ÜÇGÜL E., YILDIRIM H. Ç., et al.

JOURNAL OF CLINICAL MEDICINE , cilt.11, sa.15, 2022 (SCI-Expanded, Scopus)

30. A screening study for COVID-19-associated pulmonary aspergillosis in critically ill patients during the third wave of the pandemic

ER B., ER A. G., GÜLMEZ KIVANÇ D., ŞAHİN T. K., HALAÇLI B., DURHAN G., et al.

MYCOSES , cilt.65, ss.724-732, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

31. Relative Vaccine Effectiveness of the Third Dose of CoronaVac or BNT162b2 Following a Two-Dose CoronaVac Regimen: A Prospective Observational Cohort Study from an Adult Vaccine Center in Turkey

SÖNMEZER M. Ç., TELLİ DİZMAN G., Erul E., ŞAHİN T. K., SARICAOĞLU T., Alp A., et al.

VACCINES , cilt.10, sa.7, 2022 (SCI-Expanded, Scopus)

32. The Association between the Pan-Immune-Inflammation Value and Cancer Prognosis: A Systematic Review and Meta-Analysis

GÜVEN D. C., ŞAHİN T. K., Erul E., KILIÇKAP S., Gambichler T., AKSOY S.

CANCERS , cilt.14, sa.11, 2022 (SCI-Expanded, Scopus)

33. The burden of polypharmacy and drug-drug interactions in older cancer patients treated with immunotherapy

GÜVEN D. C., KAVGACI G., AKTEPE O. H., YILDIRIM H. H., ŞAHİN T. K., AKSOY S., et al.

JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.28, sa.4, ss.785-793, 2022 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

34. The efficacy of immune checkpoint inhibitors in rare tumors: A systematic review of published clinical trials

GÜVEN D. C., Stephen B., ŞAHİN T. K., ÇAKIR İ. Y., Erul E., AKSOY S.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , cilt.174, 2022 (SCI-Expanded, Scopus)

35. Seroprevalence of SARS-CoV-2 Antibodies and Associated Factors in Healthcare Workers before the Era of Vaccination at a Tertiary Care Hospital in Turkey

SÖNMEZER M. Ç., Erul E., ŞAHİN T. K., Rudvan Al I., Cosgun Y., Korukluoglu G., et al.

VACCINES , cilt.10, sa.2, 2022 (SCI-Expanded, Scopus)

36. Knowledge, Attitudes, and Perception towards COVID-19 Vaccination among the Adult Population: A Cross-Sectional Study in Turkey

SÖNMEZER M. Ç., ŞAHİN T. K., Erul E., Ceylan F. S., Hamurcu M. Y., Morova N., et al.

VACCINES , cilt.10, sa.2, 2022 (SCI-Expanded, Scopus)

37. Hyperlipidemia in Post-COVID patients; a unique observational follow-up study on lipid levels in post-COVID patients

UYAROĞLU O. A., ÖZDEDE M., ÇALIK BAŞARAN N., KÖYLÜ B., ŞAHİN T. K., ÖZIŞIK L., et al.

JOURNAL OF HEALTH SCIENCES AND MEDICINE , cilt.5, sa.1, ss.220-226, 2022 (TRDizin)

38. The use of fulvestrant before chemotherapy improves survival in hormone-positive breast cancer: a real-life study

GÜVEN D. C., YILDIRIM H. Ç., ERUL E., ŞAHİN T. K., ÇAKIR İ. Y., AKTEPE O. H., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.52, sa.5, ss.1551-1558, 2022 (SCI-Expanded, Scopus, TRDizin)

39. Correlation Between THSD7A Expression and Tumor Characteristics of Azoxymethane-Induced Colon Cancer Model in Rats

AKTEPE O. H., ŞAHİN T. K., GÜNER G., GÜVEN D. C., YETER H. H., KURTULAN O., et al.

TURKISH JOURNAL OF GASTROENTEROLOGY , cilt.32, sa.12, ss.1049-1056, 2021 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma

40. A systematic review and meta-analysis of the association between circulating tumor DNA (ctDNA) and prognosis in pancreatic cancer

GÜVEN D. C., ŞAHİN T. K., YILDIRIM H. Ç., AKTEPE O. H., DİZDAR Ö., YALÇIN Ş.

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY , cilt.168, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

41. Evaluation of Corrected QT Intervals of 74 COVID19 Patients Treated with Hydroxychloroquine in Combination with or without Azithromycin and/or Favipiravir

UYAROĞLU O. A., ŞENER Y. Z., ÖZDEDE M., ÇALIK BAŞARAN N., ÖZIŞIK L., ŞAHİN T. K., et al.

European Journal of Therapeutics , cilt.27, sa.4, ss.311-317, 2021 (ESCI, TRDizin) Sürdürülebilir Kalkınma

42. The Predictive Value of Red Blood Cell Distribution Width for Survival Outcomes of Metastatic Renal Cell Carcinoma Patients Treated with Targeted Therapy

AKTEPE O. H., GÜVEN D. C., ŞAHİN T. K., YILDIRIM H. Ç., ÇELİKTEN B., Yeter H. H., et al.

NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL , cilt.73, sa.10, ss.1957-1963, 2021 (SCI-Expanded, Scopus)

43. Antibody Responses to COVID-19 Vaccination in Cancer: A Systematic Review

GÜVEN D. C., ŞAHİN T. K., KILIÇKAP S., Uckun F. M.

FRONTIERS IN ONCOLOGY , cilt.11, 2021 (SCI-Expanded, Scopus)

44. Newly diagnosed cancer and the COVID-19 pandemic: tumour stage migration and higher early mortality

GÜVEN D. C., ŞAHİN T. K., YILDIRIM H. Ç., ÇEŞMECİ E., Incesu F. G. G., TAHILLIOĞLU Y., et al.

BMJ SUPPORTIVE & PALLIATIVE CARE , 2021 (SCI-Expanded, Scopus)

45. Clinical Outcomes and Independent Risk Factors for 90-Day Mortality in Critically Ill Patients with Respiratory Failure Infected with SARS-CoV-2: A Multicenter Study in Turkish Intensive Care Units

GÜNDOĞAN K., AKBUDAK İ. H., Hanci P., HALAÇLI B., TEMEL Ş., Gullu Z., et al.

BALKAN MEDICAL JOURNAL , cilt.38, sa.5, ss.296-305, 2021 (SCI-Expanded, Scopus, TRDizin)

46. Poorer baseline performance status is associated with increased thromboembolism risk in metastatic cancer patients treated with immunotherapy

GÜVEN D. C., AKSUN M. S., ŞAHİN T. K., AKTEPE O. H., YILDIRIM H. Ç., TABAN H., et al.

SUPPORTIVE CARE IN CANCER , cilt.29, sa.9, ss.5417-5423, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

47. Lower prognostic nutritional index is associated with poorer survival in patients receiving immune-checkpoint inhibitors

GÜVEN D. C., AKTEPE O. H., TABAN H., AKTAŞ B. Y., GÜNER G., YILDIRIM H. H., et al.

BIOMARKERS IN MEDICINE , cilt.15, sa.13, ss.1123-1130, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

48. THE INCIDENCE AND RISK FACTORS FOR ACUTE KIDNEY INJURY IN PATIENTS TREATED WITH IMMUNE CHECKPOINT INHIBITORS: A REAL-LIFE STUDY

GÜVEN D. C., ÖZBEK D. A., ŞAHİN T. K., AKSUN M. S., KAVGACI G., Cebrayilov C., et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION , cilt.36, 2021 (SCI-Expanded, Scopus)

49. Artificial intelligence method to predict overall survival of hepatocellular carcinoma

ŞİMŞEK C., GÜVEN D. C., Sahin T. K., TEKİN İ. E., Sahan O., BALABAN H. Y., et al.

Hepatology Forum , cilt.2, sa.2, ss.64-68, 2021 (Scopus)

50. Evaluation of emergency departments visits in patients treated with immune checkpoint inhibitors

GÜVEN D. C., ŞAHİN T. K., AKSUN M. S., TABAN H., AKTEPE O. H., METİN AKSU N., et al.

SUPPORTIVE CARE IN CANCER , cilt.29, sa.4, ss.2029-2035, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

51. Impact of albumin to globulin ratio on survival outcomes of patients with metastatic renal cell carcinoma

AKTEPE O. H., GÜNER G., GÜVEN D. C., TABAN H., YILDIRIM H. Ç., ŞAHİN T. K., et al.

TURKISH JOURNAL OF UROLOGY , cilt.47, sa.2, ss.113-119, 2021 (ESCI, Scopus, TRDizin)

52. Thyroid gland metastasis mimicking thyroid carcinoma in a lung cancer patient and dramatic response to crizotinib: A case report

Erul E., GÜVEN D. C., ŞAHİN T. K., Gullu İ. H.

TUBERKULOZ VE TORAKS-TUBERCULOSIS AND THORAX , cilt.69, sa.1, ss.98-101, 2021 (ESCI, Scopus, TRDizin)

53. Pretreatment serum uric acid level is not a surrogate marker for the outcome of favipiravir treatment in COVID-19 patients

İNKAYA A. Ç., KARA E., ÇALIK BAŞARAN N., ŞAHİN T. K., UYAROĞLU O. A., UZUN Ö., et al.

TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.51, sa.5, ss.2786-2788, 2021 (SCI-Expanded, Scopus, TRDizin)

54. The use of CDK 4/6 inhibitors in the adjuvant treatment of breast cancer: Timing matters

GÜVEN D. C., ŞAHİN T. K., AKSOY S.

BREAST JOURNAL , cilt.26, sa.12, ss.2435-2436, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

55. Predictive biomarkers for immunotherapy efficacy in non-small-cell lung cancer: current status and future perspectives

C Guven D., ŞAHİN T. K., DİZDAR Ö., KILIÇKAP S.

BIOMARKERS IN MEDICINE , cilt.14, ss.1383-1392, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

56. All Positives May Not Be the Same in Pancreatic Cancer Lessons Learned From the Past

Ceylan F., GÜVEN D. C., ŞAHİN T. K., ÖZBEK D. A., DİZDAR Ö.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS , cilt.43, sa.9, ss.676, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

57. Perspectives, Knowledge, and Fears of Cancer Patients About COVID-19

GÜVEN D. C., ŞAHİN T. K., AKTEPE O. H., YILDIRIM H. Ç., AKSOY S., KILIÇKAP S.

FRONTIERS IN ONCOLOGY , cilt.10, 2020 (SCI-Expanded, Scopus)

58. Anti-prostate cancer activity of a nanoformulation of the spleen tyrosine kinase (SYK) inhibitor C61

ŞAHİN T. K., AKTEPE O. H., Uckun F. M., YALÇIN Ş.

ANTI-CANCER DRUGS , cilt.31, sa.6, ss.609-616, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

59. Spontaneous subepithelial hemorrhage of renal pelvis and ureter (Antopol-Goldman lesion) in hemophilia A patient with inhibitor Case report and review of the literature

ŞAHİN T. K., ALADAĞ KARAKULAK E., Setterzade E., SAİN GÜVEN G., HAZNEDAROĞLU İ. C., AKSU S.

MEDICINE , cilt.99, sa.26, 2020 (SCI-Expanded, Scopus)

60. Prevention of DMBA-induced mammary gland tumors in mice by a dual-function inhibitor of JAK3 and EGF receptor tyrosine kinases

ŞAHİN K., YABAŞ M., ORHAN C., TUZCU M., ŞAHİN T. K., ÖZERCAN İ. H., et al.

EXPERT OPINION ON THERAPEUTIC TARGETS , cilt.24, sa.4, ss.379-387, 2020 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma

61. Chemopreventive efficacy of stampidine in a murine breast cancer model

ŞAHİN K., ORHAN C., ÖZERCAN İ. H., TUZCU M., ELİBOL B., ŞAHİN T. K., et al.

EXPERT OPINION ON THERAPEUTIC TARGETS , cilt.24, sa.2, ss.155-162, 2020 (SCI-Expanded, Scopus)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 4

1. SURVEILLANCE FOR INVASIVE PULMONARY ASPERGILLOSIS IN CRITICALLY ILL PATIENTS WITH COVID-19

ER B., ER A. G., GÜLMEZ KIVANÇ D., ŞAHİN T. K., HALAÇLI B., DURHAN G., et al.

18. ULUSAL DAHİLİ VE CERRAHİ BİLİMLER YOĞUN BAKIM E-KONGRESİ VE 10. AVRASYA YOĞUN BAKIM E-TOPLANTISI, Ankara, Türkiye, 6 - 09 Aralık 2021, cilt.12, (Özet Bildiri) Sürdürülebilir Kalkınma

2. ANKARA’DA BAZI AKARYAKIT İSTASYONLARINDA ÇALIŞANLARIN İSTASYONDA OLASI BİR YANGIN/PATLAMA ÖNCESİ/SIRASI/SONRASINDA YAPILACAKLAR KONUSUNDA BAZI BİLGİ VE GÖRÜŞLERİ

ERCAN T. M. F., Çakır İ. Y., ŞAHİN T. K., Ayhan B., Bulut R., GÜLBAHÇE F. G., et al.

2.Uluslararası - 20.Ulusal Halk Sağlığı Kongresi, 13 - 17 Kasım 2018, (Özet Bildiri)

3. THE EFFECTS OF BMI ON RESPIRATORY AND HEMODYNAMIC PARAMETERS IN LAPAROSCOPIC BARIATRIC SURGERY: AN OBSERVATIONAL STUDY

Ayyildiz A., PAMUK A. G., ÜZÜMCÜGİL F., AKÇA B., Yilbas A. A., ŞAHİN T. K., et al.

20th World Congress of the International-Federation-for-the-Surgery-of-Obesity-and-Metabolic-Disorders (IFSO), Vienna, Avusturya, 26 - 29 Ağustos 2015, cilt.25, (Özet Bildiri)

4. Mineralogical and geochemical characteristics of the borate bearing Kirka volcanosedimentary lacustrine basin, Gocenoluk Area, Eskisehir, Western Anatolia, Turkey: Preliminary results

ŞAHİN T. K., TEMEL A., Sylvester P.

19th Annual VM Goldschmidt Conference, Davos, İsviçre, 21 Haziran 2009, cilt.73, (Özet Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

198

H-İndeks (WoS)

Atıf (Scopus)

135

H-İndeks (Scopus)

Atıf (Scholar)

H-İndeks (Scholar)

Atıf (TrDizin)

H-İndeks (TrDizin)

Atıf (Sobiad)

H-İndeks (Sobiad)

Atıf (Diğer Toplam)

Açık Erişim

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler